According to Lincoln Pharmaceuticals latest financial reports the cash on hand of LINCOLN is $15.06M, an increase of 9.72% to 2022. At the end of 2022 company had $13.72M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $15.06M | 9.72% |
2022 | $13.72M | 24.99% |
2021 | $10.98M | 98.21% |
2020 | $5.54M | 97.27% |
2019 | $2.81M | - |